Skip to content

Effect of Ayurvedic Eye Treatment in Diabetic Retinopathy

In vivo and Clinical Study To Evaluate The Efficacy Of Katakakhadiradi Ghana Vati Tiktaka Ghrita Tarpan In Pramehajanya Timira With Special Reference To Non Proliferative Diabetic Retinopathy A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046903
Enrollment
60
Registered
2022-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H36- Retinal disorders in diseases classified elsewhere

Interventions

None listed

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients in the age group of 20 to 70 years 2.Known cases of Type I and Type II diabetes mellitus with 5years of history 3.Patients with well controlled blood sugar level 4.Patients with visual symptoms like blurring of vision, floaters etc 5.Patients with mild to moderate NPDR 6.Patients willing to give written consent

Exclusion criteria

Exclusion criteria: 1.Patients with severe NPDR or with PDR, Diabetic Maculopathy. 2.Patients with Diabetic Retinopathy with complications like Retinal detachment, posterior vitreal detachment, acute vitrealhemorrhage, Rubiosis Iridis. 3.Gestational Diabetic Retinopathy. 4.Severe visual impairments like high Myopia, Retinitis Pigmentosa, Mature Cataract, post Cataract surgeries, Glaucoma. 5.Patients with other systemic complaints like Hypertension, Renal impairment, COPD, cardiovascular diseases.

Design outcomes

Primary

MeasureTime frame
Changes in the Visual acuity in 30 days of interventionTimepoint: 30 days

Secondary

MeasureTime frame
Improvement in Best corrected visual acuity, clinical findings of fundoscopy, OCT findings. Improvement in the symptoms like blurred vision, flashes, floaters , dark adaptation, retinal haemorrhagesTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Malashree Sadashiv Gadadi

National Institute of Ayurveda jaipur

Shamsa_fiaz@yahoo.com9036616056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026